ストックスクリーナーアプリを入手
9.16
2.35%
0.21
プレマーケット:
9.29
0.13
+1.42%
前日終値:
$8.95
開ける：
$8.915
24時間の取引高:
2.62M
Relative Volume:
0.47
時価総額：
$2.12B
収益：
$509.86M
当期純損益:
$165.35M
株価収益率:
13.51
EPS:
0.6779
ネットキャッシュフロー:
$107.55M
1週間 パフォーマンス:
+9.44%
1か月 パフォーマンス:
+14.93%
6か月 パフォーマンス:
-50.05%
1年 パフォーマンス:
-49.89%
1日の値動き範囲:
$8.84
$9.17
1週間の範囲:
$8.29
$9.17
52週間の値動き範囲:
$7.2101
$20.46
Adma Biologics Inc Stock (ADMA) Company Profile
Compare ADMA vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ADMA
Adma Biologics Inc
|
9.16 | 1.94B | 509.86M | 165.35M | 107.55M | 0.6779 |
VRTX
Vertex Pharmaceuticals Inc
|
529.59 | 126.07B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
649.81 | 65.37B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
916.80 | 57.70B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
313.04 | 40.19B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
189.99 | 39.82B | 742.00K | -1.37B | -1.07B | -7.0731 |
Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-21 | 開始されました | Canaccord Genuity | Buy |
| 2026-03-26 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2023-07-19 | 再開されました | Raymond James | Strong Buy |
| 2022-10-13 | 開始されました | Mizuho | Buy |
| 2021-11-11 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2021-11-09 | 開始されました | Cantor Fitzgerald | Overweight |
| 2019-06-04 | 開始されました | Jefferies | Buy |
| 2019-04-15 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-02-07 | 再開されました | H.C. Wainwright | Buy |
| 2017-12-11 | 繰り返されました | Maxim Group | Buy |
| 2017-11-14 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2017-01-23 | アップグレード | Maxim Group | Hold → Buy |
| 2016-08-01 | ダウングレード | Maxim Group | Buy → Hold |
| 2016-07-25 | 繰り返されました | Maxim Group | Buy |
| 2015-05-13 | 繰り返されました | Maxim Group | Buy |
| 2014-12-08 | 開始されました | Oppenheimer | Outperform |
| 2014-12-01 | 繰り返されました | Maxim Group | Buy |
すべてを表示
Adma Biologics Inc (ADMA) 最新ニュース
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Nano-X Imaging Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action – NNOX - GlobeNewswire Inc.
ADMA Biologics, Inc. (ADMA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
ADMA Biologics, Inc. Class Action Lawsuit Seeks Recovery - GlobeNewswire
ADMA DEADLINE: Levi & Korsinsky Reminds ADMA BIOLOGICS, INC. Investors of Upcoming Securities Class Action Deadline - PR Newswire
ADMA BIOLOGICS, INC. INVESTORS WITH LOSSES HAVE UNTIL - GlobeNewswire
ADMA Stock Downgraded By Cantor As ‘Channel Stuffing’ Claims Shake Investor Confidence - Stocktwits
ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - GlobeNewswire Inc.
ADMA Faruqi & Faruqi, LLP Reminds ADMA Biologics Investors of Securities Class Action Lawsuit Deadline on August 10, 2026 - marketscreener.com
ADMA Tumbles On Slashed Outlook As Short-Seller Aftermath Meets Competitive Headwinds - Stocktwits
Trading Systems Reacting to (ADMA) Volatility - Stock Traders Daily
ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire
ADMA Biologics (NASDAQ: ADMA) Investigated for Potential - GlobeNewswire
ADMA Biologics, Inc. (ADMA) Investigation: Bronstein, Gewirtz & G - The National Law Review
$ADMA Notification: ADMA Biologics Accused of Misrepresentations about its Revenue Sources in Securities Fraud Class Action - TradingView
Adma Biologics (ADMA) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo! Finance Canada
ADMA BIOLOGICS, INC. INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates ADMA Biologics, Inc.’s Directors and Officers for Breach of Fiduciary Duties – ADMA - Business Wire
ROSEN, SKILLED INVESTOR COUNSEL, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the FirmADMA - TMX Newsfile
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff - GlobeNewswire
Lead Plaintiff Deadlines in Shareholder Class Action - GlobeNewswire
Investor Announcement: ADMA Biologics Investors are Notified to Contact BFA Law about the Pending Securities Fraud Class Action to Recover Stock Losses - GlobeNewswire
ADMA Biologics, Inc.(NasdaqGM: ADMA) added to Russell 2000 Growth-Defensive Index - marketscreener.com
ADMA Biologics, Inc. (ADMA) Class Action Lawsuit Seeks Recovery for Investors; August 10, 2026, DeadlineContact Kessler Topaz Meltzer & Check, LLP - NewMediaWire
ADMA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ADMA Biologics, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
ADMA Biologics Faces Securities Fraud Class Action Lawsuit - Intellectia AI
ADMA Biologics, Inc. Actuals & Estimates (NASDAQ:ADMA) - TradingView
Kessler Topaz Meltzer & Check, LLP - GlobeNewswire Inc.
Did You Lose Money on ADMA Biologics, Inc. (ADMA)? Levi & Korsinsky Urges Investors to Act Before August 10, 2026 - ACCESS Newswire
Levi & Korsinsky Urges ADMA Biologics, Inc. (ADMA) Shareholders to Act Before Lead Plaintiff Deadline August 10, 2026 - ACCESS Newswire
ADMA Biologics, Inc. Actuals & Estimates (BX:ADMA) - TradingView
Levi & Korsinsky Notifies ADMA Biologics, Inc. (ADMA) Shareholders of Class Action Lawsuit and August 10, 2026 Deadline - ACCESS Newswire
ADMA Biologics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against ADMA Biologics, Inc.ADMA - PR Newswire
ADMA SHAREHOLDER ALERT: Securities Fraud Lawsuit Filed on Behalf of ADMA Biologics, Inc. Investors - GlobeNewswire Inc.
ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm - The Keene Sentinel
Class Action Lawsuit Filed Against ADMA Biologics, Inc. (ADMA)Recover LossesContact Levi & Korsinsky Before August 10, 2026 - ACCESS Newswire
ADMA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ADMA Biologics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Deadline Alert: ADMA Biologics, Inc. (ADMA) Shareholders - GlobeNewswire
DEADLINE ALERT for VIA, Z, and ADMA: The Law Offices of - GlobeNewswire
ADMA Shareholder Alert: ADMA Biologics, Inc. Securities - GlobeNewswire
ADMA Biologics, Inc. (ADMA) Investors: August 10, 2026, Deadline in Securities Fraud Class Action Lawsuit - The Globe and Mail
ADMA Biologics Inc (ADMA) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
ADMA Biologics, Inc. Actuals & Estimates (BOATS:ADMA) - TradingView
Price to earnings forward of ADMA Biologics Inc – NASDAQ:ADMA - TradingView
Enterprise value to revenue forward of ADMA Biologics Inc – NASDAQ:ADMA - TradingView
What Are the Allegations Against ADMA Biologics - Kavout | AI
ADMA LAWSUIT ALERT: Levi & Korsinsky Notifies ADMA Biologics, Inc. InvestorsLead Plaintiff Deadline August 10, 2026 - ACCESS Newswire
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by The FirmADMA - ACCESS Newswire
Contact Levi & Korsinsky by August 10, 2026 to Join Class Action Against ADMA Biologics, Inc. (ADMA) - ACCESS Newswire
Class Action Lawsuit Alert: Levi & Korsinsky Reminds ADMA Biologics, Inc. (ADMA) Investors of August 10, 2026 Deadline - ACCESS Newswire
Enterprise value to EBITDA forward of ADMA Biologics Inc – NASDAQ:ADMA - TradingView
Lost Money on ADMA Biologics, Inc. (ADMA)? Contact Levi & Korsinsky Before August 10, 2026 to Join Class Action - ACCESS Newswire
ROSEN, THE FIRST FILING FIRM, Encourages ADMA Biologics, Inc. Investors to Secure Counsel ... - Caledonian Record
Adma Biologics Inc (ADMA) 財務データ
収益
当期純利益
現金流量
EPS
Adma Biologics Inc (ADMA) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Grossman Jerrold B | Director |
May 12 '26 |
Buy |
8.01 |
12,500 |
100,125 |
513,884 |
| Grossman Jerrold B | Director |
May 11 '26 |
Buy |
8.01 |
12,500 |
100,125 |
501,384 |
| Guiheen Lawrence P. | Director |
Mar 13 '26 |
Option Exercise |
3.66 |
30,000 |
109,800 |
135,520 |
| Grossman Adam S | President and CEO |
Mar 16 '26 |
Option Exercise |
5.40 |
15,000 |
81,000 |
2,133,777 |
| Grossman Adam S | President and CEO |
Mar 16 '26 |
Sale |
15.16 |
21,000 |
318,360 |
2,112,777 |
0.05%
0.74%
大文字化:
|
ボリューム (24 時間):